By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Novartis this week said that it will invest more than $600 million over the next five years to expand its global research campus in Cambridge, Mass. The Cambridge site houses the Novartis Institutes for Biomedical Research, Novartis Molecular Diagnostics, Novartis Vaccines and Diagnostics, and the US office of Novartis Venture Funds.

The company expects the investment will include adding 300 jobs, however a company spokesperson declined to provide further details.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.